Hepatectomy and lung radiofrequency ablation for hepatic and subsequent pulmonary metastases from colorectal carcinoma
Authors:
- Tristan D. YanTYTristan D. Yan
- Ardalan EbrahimiAEArdalan Ebrahimi
- Adrian SjarifASAdrian Sjarif
- Derek GlennDGDerek Glenn
- David L. MorrisDMDavid L. Morris
- 18 April 2007
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 96 (5) , 367-373
Abstract
Background: Lung radiofrequency ablation (RFA) is a relatively safe procedure and may have a useful role in the management of non‐surgical candidates with colorectal pulmonary metastases.Methods: This study consisted of 30 patients, who had previously undergone hepatectomy for colorectal liver metastases and subsequently developed pulmonary metastases, which were then treated with lung RFA. Lung RFA was performed percutaneously under local anesthesia and conscious sedation. The primary aim of this article was to demonstrate the survival outcome in this particular patient population after lung RFA. The secondary aim was to assess the prognostic indicators for survival after lung RFA.Results: The median survival after lung RFA was 32 months, with 3‐year survival rate of 45%. The following four factors were found to significantly influence survival in univariate analysis: size of the largest pulmonary metastasis (P = 0.032), proximity of metastases to major pulmonary vessels (P = 0.003), pre‐lung RFA CEA levels (P = 0.013) and post‐lung RFA CEA levels (P = 0.022).Conclusions: Lung RFA may have a useful role in the management of non‐surgical candidates with colorectal pulmonary metastases. J. Surg. Oncol. 2007;96:367–373.Keywords
This publication has 26 references indexed in Scilit:
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet, 2000
- Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal CancerJournal of Clinical Oncology, 2000
- Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerThe Lancet, 1998
- Resection of Colorectal Liver Metastases: 25‐Year ExperienceWorld Journal of Surgery, 1998
- Pulmonary resection for metastatic colorectal cancer: Experiences with 159 patientsThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Pulmonary Resection for Metastases of Colorectal OriginChest, 1995
- Chemotherapy for Colorectal CancerNew England Journal of Medicine, 1994
- Surgical treatment of liver metastases in patients with colorectal cancerCancer, 1993